Search research articles
Contact Us
Filters
Showing results (201-210 of 247) with videos related to
Page
of 25
Sort By:
Breast Cancer Research and Treatment
|
June 13, 2024
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
Manali A Bhave, Julia C F Quintanilha, Hanna Tukachinsky, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 7, 2023
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer
Breana L Hill, Ryon P Graf, Kunal Shah, et al.
JCO Precision Oncology
|
July 6, 2023
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness
Julia C F Quintanilha, Michael H Storandt, Ryon P Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
Himisha Beltran, Adam Jendrisak, Mark Landers, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data
M J Emmett, J C F Quintanilha, R P Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2022
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer
Umang Swami, Ryon P Graf, Roberto H Nussenzveig, et al.
JAMA Network Open
|
January 23, 2023
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden
Julia C F Quintanilha, Ryon P Graf, Virginia A Fisher, et al.
JAMA Oncology
|
June 30, 2018
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
Howard I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C
D J Propper, A C McDonald, A Man, et al.
NPJ Breast Cancer
|
May 20, 2026
Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy results
Kristina Fanucci, Mariya Rozenblit, Julia C F Quintanilha, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 247) with videos related to
Sort By:
Page
of 25
Breast Cancer Research and Treatment
|
June 13, 2024
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
Manali A Bhave, Julia C F Quintanilha, Hanna Tukachinsky, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 7, 2023
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer
Breana L Hill, Ryon P Graf, Kunal Shah, et al.
JCO Precision Oncology
|
July 6, 2023
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness
Julia C F Quintanilha, Michael H Storandt, Ryon P Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
Himisha Beltran, Adam Jendrisak, Mark Landers, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data
M J Emmett, J C F Quintanilha, R P Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2022
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer
Umang Swami, Ryon P Graf, Roberto H Nussenzveig, et al.
JAMA Network Open
|
January 23, 2023
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden
Julia C F Quintanilha, Ryon P Graf, Virginia A Fisher, et al.
JAMA Oncology
|
June 30, 2018
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
Howard I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C
D J Propper, A C McDonald, A Man, et al.
NPJ Breast Cancer
|
May 20, 2026
Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy results
Kristina Fanucci, Mariya Rozenblit, Julia C F Quintanilha, et al.
Page
of 25